Kang Y Michele 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jun 2, 2009
Insider Transaction Report
Form 4
Kang Y Michele
Director
Transactions
- Award
Stock Options (right to buy)
2009-06-01+20,000→ 20,000 totalExercise: $1.28Exp: 2019-06-01→ Common Stock (20,000 underlying)
Holdings
- 150,000
Stock Options (right to buy)
Exercise: $1.47Exp: 2018-08-12→ Common Stock (150,000 underlying) - 20,000
Stock Options (right to buy)
Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]These options vest and become exercisable in full on June 30, 2009.
- [F2]30% of the options vest and become exercisable on August 12, 2009; another 30% of the options vest and become exercisable on August 12, 2010; and the remaining 40% of the options vest and became exercisable on August 12, 2011.
- [F3]These options vest and become exercisable in full on June 1, 2010.